Validity and Reliability of CTQ-SSS in Carpal Tunnel Syndrome.
Validity and Reliability of the Shorter Version of the CTQ-SSS in Patients With Carpal Tunnel Syndrome: A Cross-sectional Study
1 other identifier
observational
50
1 country
1
Brief Summary
To determine the validity and reliability of the shorter version of the CTQ-SSS in patients with carpal tunnel syndrome (CTS) undergoing nonsurgical management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2023
CompletedStudy Start
First participant enrolled
May 1, 2023
CompletedFirst Posted
Study publicly available on registry
May 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedMay 3, 2023
April 1, 2023
4 months
April 20, 2023
April 20, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Validity and Reliability of the Shorter Version of the CTQ-SSS
To determine the validity and reliability of the shorter version of the CTQ-SSS in patients with carpal tunnel syndrome undergoing nonsurgical management. The CTQ-SSS will be administered at baseline and at a follow-up visit within 2-4 weeks to assess test-retest reliability. Internal consistency will be assessed using Cronbach's alpha coefficient. Construct validity will be assessed by comparing the CTQ-SSS scores with other functional measures such as the DASH questionnaire and PRWE using Pearson's correlation coefficient.
Outcome measures will be assessed within 2-4 weeks of the initial CTQ-SSS administration.
Study Arms (1)
Study Participants
This group will consist of at least 50 patients with carpal tunnel syndrome who are undergoing nonsurgical management. Participants will complete the shorter version of the CTQ-SSS and other functional measures, such as the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire and the Patient-Rated Wrist Evaluation (PRWE). The validity and reliability of the CTQ-SSS will be assessed in this group using test-retest reliability and internal consistency analyses, as well as construct validity analyses comparing CTQ-SSS scores with other functional measures.
Interventions
The intervention in this study is the administration of the shorter version of the CTQ-SSS, a validated questionnaire designed to assess the severity of symptoms and functional limitations associated with carpal tunnel syndrome. The CTQ-SSS consists of 8 items related to symptom severity and 2 items related to functional status. The scores for each set of items are combined to generate symptom severity and functional status scores, which will be used to assess the validity and reliability of the CTQ-SSS in patients with carpal tunnel syndrome undergoing nonsurgical management.
Eligibility Criteria
The study population will consist of patients with carpal tunnel syndrome who are undergoing nonsurgical management.
You may qualify if:
- Patients diagnosed with carpal tunnel syndrome based on clinical presentation and/or nerve conduction studies.
- Patients aged 18 years to 60 years old.
- Patients who are undergoing nonsurgical management for carpal tunnel syndrome.
You may not qualify if:
- Patients with a history of hand or wrist surgery within the past 6 months.
- Patients with severe hand or wrist pain that would prevent completion of the outcome measures or interfere with their ability to participate in the study.
- Patients with severe cognitive impairment or language barrier that would prevent understanding of the study instructions or interfere with their ability to participate in the study.
- Patients with any other medical condition that could affect hand function or interfere with test completion.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Outpatient clinic of faculty of physical therapy, Ahram Canadian University
Al Ḩayy Ath Thāmin, Giza Governorate, 3221405, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Amal Fawzy, Ph.d
Faculty of Physical Therapy, Ahram Canadian University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Physical Therapy and Director of Electromyography Lab
Study Record Dates
First Submitted
April 20, 2023
First Posted
May 3, 2023
Study Start
May 1, 2023
Primary Completion
September 1, 2023
Study Completion
October 1, 2023
Last Updated
May 3, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- During the trial and after the trial by 6 months
- Access Criteria
- via email to mohamed.elmeligie@acu.edu.eg
The individual participant data (IPD) collected during this study will be available upon reasonable request. Requests for access to the data should be submitted via email to mohamed.elmeligie@acu.edu.eg. All requests will be reviewed by the study investigators to ensure that they are reasonable and consistent with the ethical principles of the study. Access to the data will be granted in compliance with applicable laws and regulations, and with appropriate safeguards to protect the privacy and confidentiality of study participants.